Ilsung Is Co., Ltd.
Research Ilsung Is Co., Ltd. (003120.KS) on Bullrun: market cap KRW 156.49B, dividend yield 5.7%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker003120.KS
- ExchangeKS
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 156.49B
- Dividend yield5.7%
- Financial periodQ2 2026
- RevenueKRW 17.09B
- Net incomeKRW 216.95M
- Free cash flow-KRW 606.79M
- Gross margin44.3%
Valuation Snapshot
latest market cap is KRW 156.49B; dividend yield is 5.7%.
Peer valuation comparison
Latest dividend yield is 5.74% versus a Healthcare sector median of 2.4% (139.2% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 156.49B | n/a | 5.5% | 1200 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1200 KRW, yield 5.7%.
About Ilsung Is Co., Ltd.
Ilsung Is Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, antipyretic-analgesics, antihistamine, neuropsychiatric, neuromuscular blocker/ central muscle relaxants, anti-coagulants, probiotics, vaccine, medical equipment, circulatory system drugs, contrast agents, muscle relaxants, diabetes treatments, osteopathic, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, adrenal cortical steroids, anesthetics,...
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Ilsung Is Co., Ltd.'s market cap?
Ilsung Is Co., Ltd.'s market capitalization is KRW 156.49B.
Does Ilsung Is Co., Ltd. pay a dividend?
Ilsung Is Co., Ltd. has a dividend yield of 5.7%.
What does Ilsung Is Co., Ltd. do?
Ilsung Is Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, antipyretic-analgesics, antihistamine, neuropsychiatric, neuromuscular blocker/ central muscle relaxants, anti-coagulants, probiotics, vaccine, medical equipment, circulatory system drugs, contrast agents, muscle relaxants, diabetes treatments, osteopathic, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, adrenal cortical steroids, anesthetics, antipyretics, and cardiovascular system products.